חזרה לתוצאות החיפוש

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

ישראלפעיל (ללא גיוס)PHASE1

מצבים רפואיים

Hepatocellular Carcinoma · Pancreatic Ductal Adenocarcinoma · Biliary Tract Cancers · Esophageal Squamous Cell Carcinoma · Triple Negative Breast Cancer · Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer · Head and Neck Squamous-Cell Carcinoma · Platinum Resistant High Grade Epithelial Ovarian Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • City of Hope National Medical Center /ID# 258645, Duarte, California, United States

  • Ucsf /Id# 257705, San Francisco, California, United States

  • University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128, Aurora, Colorado, United States

  • Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926, Denver, Colorado, United States

  • Florida Cancer Specialists /ID# 261569, Sarasota, Florida, United States

  • Northwestern University Feinberg School of Medicine /ID# 257378, Chicago, Illinois, United States

  • University of Chicago Medical Center /ID# 258197, Chicago, Illinois, United States

  • START Midwest /ID# 256581, Grand Rapids, Michigan, United States

  • Washington University-School of Medicine /ID# 257379, St Louis, Missouri, United States

  • Memorial Sloan Kettering Cancer Center-Koch Center /ID# 255132, New York, New York, United States

  • Duke Cancer Center /ID# 255129, Durham, North Carolina, United States

  • Univ Hosp Cleveland /ID# 257706, Cleveland, Ohio, United States

  • Lifespan Cancer Institute at Rhode Island Hospital /ID# 257693, Providence, Rhode Island, United States

  • MUSC Hollings Cancer Center /ID# 257935, Charleston, South Carolina, United States

  • Prisma Health /ID# 257697, Greenville, South Carolina, United States

  • Tennessee Oncology-Nashville Centennial /ID# 261568, Nashville, Tennessee, United States

  • MD Anderson Cancer Center /ID# 255131, Houston, Texas, United States

  • Univ Texas HSC San Antonio /ID# 257708, San Antonio, Texas, United States

  • South Texas Accelerated Research Therapeutics /ID# 260404, San Antonio, Texas, United States

  • Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 262771, Fairfax, Virginia, United States

  • Chris O'Brien Lifehouse /ID# 262765, Camperdown, New South Wales, Australia

  • Austin Health /ID# 256635, Heidelberg, Victoria, Australia

  • The Chaim Sheba Medical Center /ID# 255731, Ramat Gan, Tel Aviv, Israel

  • Tel Aviv Sourasky Medical Center /ID# 258931, Tel Aviv, Tel Aviv, Israel

  • Rambam Health Care Campus /ID# 256649, Haifa, Israel

  • Hadassah Medical Center-Hebrew University /ID# 256655, Jerusalem, Israel

  • Rabin Medical Center. /ID# 256650, Petah Tikva, Israel

  • NHO Nagoya Medical Center /ID# 261001, Nagoya, Aichi-ken, Japan

  • Aichi Cancer Center Hospital /ID# 256679, Nagoya, Aichi-ken, Japan

  • National Cancer Center Hospital East /ID# 258934, Kashiwa-shi, Chiba, Japan

  • Kyoto University Hospital /ID# 256680, Kyoto, Kyoto, Japan

  • Shizuoka Cancer Center /ID# 257789, Sunto-gun, Shizuoka, Japan

  • National Cancer Center Hospital /ID# 261136, Chuo-Ku, Tokyo, Japan

  • The Cancer Institute Hospital Of JFCR /ID# 257788, Koto-ku, Tokyo, Japan

  • Pan American Center for Oncology Trials /ID# 262903, Rio Piedras, Puerto Rico

  • Inje University Haeundae Paik Hospital /ID# 260118, Busan, Busan Gwang Yeogsi, South Korea

  • Gyeongsang National University Hospital /ID# 260408, Jinju, Gyeongsangnam-do, South Korea

  • Chungbuk National University Hospital /ID# 256698, Cheongju-si, North Chungcheong, South Korea

  • Seoul National University Hospital /ID# 255730, Seoul, Seoul Teugbyeolsi, South Korea

  • Samsung Medical Center /ID# 258933, Seoul, Seoul Teugbyeolsi, South Korea

  • Korea University Guro Hospital /ID# 256700, Seoul, Seoul Teugbyeolsi, South Korea

  • Institut Català d'Oncologia (ICO) - Badalona /ID# 263954, Badalona, Barcelona, Spain

  • Hospital Quirón Málaga /ID# 263994, Málaga, Malaga, Spain

  • Clinica Universidad de Navarra - Pamplona /ID# 256703, Pamplona, Navarre, Spain

  • Hospital HM Nou Delfos /ID# 263953, Barcelona, Spain

  • Hospital General Universitario Gregorio Maranon /ID# 262816, Madrid, Spain

  • Clinica Universidad de Navarra - Madrid /ID# 264042, Madrid, Spain

  • Hospital Universitario Fundacion Jimenez Diaz /ID# 256702, Madrid, Spain

  • Hospital Universitario HM Sanchinarro /ID# 256701, Madrid, Spain

  • Hospital Universitario Miguel Servet /ID# 256704, Zaragoza, Spain

  • E-DA Cancer Hospital /ID# 258880, Kaohsiung City, Kaohsiung, Taiwan

  • National Taiwan University Hospital /ID# 256713, Taipei City, Taipei, Taiwan

  • China Medical University Hospital /ID# 256712, Taichung, Taiwan

  • Linkou Chang Gung Memorial Hospital /ID# 259420, Taoyuan City, Taiwan

מובילי המחקר

  • ABBVIE INC.

    Study Director

    AbbVie

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)